Reset Map3 Results
PO Box 6492, Melbourne Victoria 3004, AustraliaBaker IDI is one of the few institutes in the world where the work of staff spans benchtop to bedside and where research is dedicated to tackling the deadly trio of diseases: cardiovascular disease, diabetes and obesity. The Institute’s science strategy reflects the breadth of the areas that we work across in order to enhance the diagnosis, prevention and treatment of chronic disease. In order to ensure that our work is relevant to the communities in which we operate, the strategy reflects a strong focus on collaboration and translation, tackling big-picture health questions and working with investors, industry and government to drive better health. Our strategies To retain the Institute's traditional independence, flexibility, agility and specialised focus. To collaborate extensively with hospitals, universities and other research institutes locally and around the world. Baker IDI's research activities will continue to be driven by an intention to contribute to a global reduction in death and disability from cardiovascular disease, diabetes and associated metabolic diseases. The Institute's output will be self-evidently translational through the mechanisms of technology transfer and commercialisation, involvement in and support of the direct delivery of clinical services, and influencing policy and guidelines. Baker IDI will remain a pre-eminent contributor to Australian, regional and global academic output in medical research through traditional peer-reviewed mechanisms and metrics. The Institute will develop the capacity to fund, manage and support basic and clinical research and research translation outside the confines of peer-reviewed grant and publication processes. Whilst much research will continue to be investigator-driven, specific programs of research will be thematically consistent with the overall disease mitigation objectives in the Institute's mission. Baker IDI will have an open, flexible and collaborative culture with mutual recognition and respect of the contributions made within the organisation across all disciplines.
75 Commercial Road, Melbourne, Victoria 3004, AustraliaBaker IDI is one of the few institutes in the world where the work of staff spans benchtop to bedside and where research is dedicated to tackling the deadly trio of diseases: cardiovascular disease, diabetes and obesity. The Institute’s science strategy reflects the breadth of the areas that we work across in order to enhance the diagnosis, prevention and treatment of chronic disease. In order to ensure that our work is relevant to the communities in which we operate, the strategy reflects a strong focus on collaboration and translation, tackling big-picture health questions and working with investors, industry and government to drive better health. Our strategies To retain the Institute's traditional independence, flexibility, agility and specialised focus. To collaborate extensively with hospitals, universities and other research institutes locally and around the world. Baker IDI's research activities will continue to be driven by an intention to contribute to a global reduction in death and disability from cardiovascular disease, diabetes and associated metabolic diseases. The Institute's output will be self-evidently translational through the mechanisms of technology transfer and commercialisation, involvement in and support of the direct delivery of clinical services, and influencing policy and guidelines. Baker IDI will remain a pre-eminent contributor to Australian, regional and global academic output in medical research through traditional peer-reviewed mechanisms and metrics. The Institute will develop the capacity to fund, manage and support basic and clinical research and research translation outside the confines of peer-reviewed grant and publication processes. Whilst much research will continue to be investigator-driven, specific programs of research will be thematically consistent with the overall disease mitigation objectives in the Institute's mission. Baker IDI will have an open, flexible and collaborative culture with mutual recognition and respect of the contributions made within the organisation across all disciplines.
5 Commercial Road Melbourne, Victoria, 3004 AustraliaBaker IDI is one of the few institutes in the world where the work of staff spans benchtop to bedside and where research is dedicated to tackling the deadly trio of diseases: cardiovascular disease, diabetes and obesity. The Institute’s science strategy reflects the breadth of the areas that we work across in order to enhance the diagnosis, prevention and treatment of chronic disease. In order to ensure that our work is relevant to the communities in which we operate, the strategy reflects a strong focus on collaboration and translation, tackling big-picture health questions and working with investors, industry and government to drive better health. Our strategies To retain the Institute's traditional independence, flexibility, agility and specialised focus. To collaborate extensively with hospitals, universities and other research institutes locally and around the world. Baker IDI's research activities will continue to be driven by an intention to contribute to a global reduction in death and disability from cardiovascular disease, diabetes and associated metabolic diseases. The Institute's output will be self-evidently translational through the mechanisms of technology transfer and commercialisation, involvement in and support of the direct delivery of clinical services, and influencing policy and guidelines. Baker IDI will remain a pre-eminent contributor to Australian, regional and global academic output in medical research through traditional peer-reviewed mechanisms and metrics. The Institute will develop the capacity to fund, manage and support basic and clinical research and research translation outside the confines of peer-reviewed grant and publication processes. Whilst much research will continue to be investigator-driven, specific programs of research will be thematically consistent with the overall disease mitigation objectives in the Institute's mission. Baker IDI will have an open, flexible and collaborative culture with mutual recognition and respect of the contributions made within the organisation across all disciplines.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.